{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:44:31Z","timestamp":1761101071046},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,28]],"date-time":"2011-02-28T00:00:00Z","timestamp":1298851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,2,28]],"date-time":"2011-02-28T00:00:00Z","timestamp":1298851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/bmt.2011.29","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T23:28:21Z","timestamp":1299022101000},"page":"82-87","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"47","author":[{"given":"D G","family":"Stover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V K","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B N","family":"Savani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,28]]},"reference":[{"key":"BFbmt201129_CR1","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540\u20131545.","journal-title":"N Engl J Med"},{"key":"BFbmt201129_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3816\/CLM.2000.n.004","volume":"1","author":"A Nademanee","year":"2000","unstructured":"Nademanee A, Molina A, Dagis A, Snyder DS, O\u2019Donnell MR, Parker P et al. Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma. Clin Lymphoma 2000; 1: 46\u201354.","journal-title":"Clin Lymphoma"},{"key":"BFbmt201129_CR3","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1111\/j.1537-2995.2009.02202.x","volume":"49","author":"DH Yoon","year":"2009","unstructured":"Yoon DH, Sohn BS, Jang G, Kim EK, Kang BW, Kim C et al. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma. Transfusion 2009; 49: 1890\u20131900.","journal-title":"Transfusion"},{"key":"BFbmt201129_CR4","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.bbmt.2009.07.017","volume":"15","author":"TS Fenske","year":"2009","unstructured":"Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ et al. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biol Blood Marrow Transplant 2009; 15: 1455\u20131464.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201129_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.bmt.1704050","volume":"31","author":"LN Gordan","year":"2003","unstructured":"Gordan LN, Sugrue MW, Lynch JW, Williams KD, Khan SA, Moreb JS . Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma. Bone Marrow Transplant 2003; 31: 1009\u20131013.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201129_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1182\/blood.V98.3.579","volume":"98","author":"LF Porrata","year":"2001","unstructured":"Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 2001; 98: 579\u2013585.","journal-title":"Blood"},{"key":"BFbmt201129_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.bbmt.2008.04.013","volume":"14","author":"LF Porrata","year":"2008","unstructured":"Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Gastineau DA et al. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol Blood Marrow Transplant 2008; 14: 807\u2013816.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201129_CR8","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1200\/JCO.1999.17.8.2454","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Vena DA, Barrett J, Freidlin B . Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol 1999; 17: 2454\u20132460.","journal-title":"J Clin Oncol"},{"key":"BFbmt201129_CR9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/sj.bmt.1705373","volume":"37","author":"H Kim","year":"2006","unstructured":"Kim H, Sohn HJ, Kim S, Lee JS, Kim WK, Suh C . Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplant 2006; 37: 1037\u20131042.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201129_CR10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1078-0432.1210.11.3","volume":"11","author":"LF Porrata","year":"2005","unstructured":"Porrata LF, Gertz MA, Litzow MR, Lacy MQ, Dispenzieri A, Inwards DJ et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Clin Cancer Res 2005; 11: 1210\u20131218.","journal-title":"Clin Cancer Res"},{"key":"BFbmt201129_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.bmt.1704355","volume":"33","author":"LF Porrata","year":"2004","unstructured":"Porrata LF, Litzow MR, Inwards DJ, Gastineau DA, Moore SB, Pineda AA et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 291\u2013298.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201129_CR12","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","volume":"103","author":"M Ghielmini","year":"2004","unstructured":"Ghielmini M, Schmitz SF, Cogliatti SB, Pichert G, Hummerjohann J, Waltzer U et al. Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule. Blood 2004; 103: 4416\u20134423.","journal-title":"Blood"},{"key":"BFbmt201129_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bmt.1705342","volume":"37","author":"C Joao","year":"2006","unstructured":"Joao C, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB et al. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma. Bone Marrow Transplant 2006; 37: 865\u2013871.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201129_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/sj.bmt.1705795","volume":"40","author":"D Tiwari","year":"2007","unstructured":"Tiwari D, Gao F, Hidalgo J, Adkins DR, Vij R, DiPersio JF et al. Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma. Bone Marrow Transplant 2007; 40: 671\u2013675.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201129_CR15","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1080\/10428190802226425","volume":"49","author":"MC Cox","year":"2008","unstructured":"Cox MC, Nofroni I, Ruco L, Amodeo R, Ferrari A, La Verde G et al. Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma. Leuk Lymphoma 2008; 49: 1745\u20131751.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt201129_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bbmt.2009.10.029","volume":"16","author":"LF Porrata","year":"2010","unstructured":"Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ et al. New-onset lymphopenia assessed during routine follow-up is a risk factor for relapse postautologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma. Biol Blood Marrow Transplant 2010; 16: 376\u2013383.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201129_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1600-0609.2008.01129.x","volume":"81","author":"Y Oki","year":"2008","unstructured":"Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y et al. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients\u2019 survival benefit from rituximab. Eur J Haematol 2008; 81: 448\u2013453.","journal-title":"Eur J Haematol"},{"key":"BFbmt201129_CR18","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1182\/blood.V92.5.1471","volume":"92","author":"T Guillaume","year":"1998","unstructured":"Guillaume T, Rubinstein DB, Symann M . Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471\u20131490.","journal-title":"Blood"},{"key":"BFbmt201129_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/blood-2003-04-1257","volume":"103","author":"SM Horwitz","year":"2004","unstructured":"Horwitz SM, Negrin RS, Blume KG, Breslin S, Stuart MJ . Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 2004; 103: 777\u2013783.","journal-title":"Blood"},{"key":"BFbmt201129_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.bmt.1704742","volume":"35","author":"SH Lim","year":"2005","unstructured":"Lim SH, Zhang Y, Wang Z, Esler WV, Beggs D . Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia. Bone Marrow Transplant 2005; 35: 207\u2013208.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201129_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","volume":"108","author":"RA Roberts","year":"2006","unstructured":"Roberts RA, Wright G, Rosenwald AR, Jaramillo MA, Grogan TM . Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. Blood 2006; 108: 311\u2013318.","journal-title":"Blood"},{"key":"BFbmt201129_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/10428190701824536","volume":"49","author":"NR Lee","year":"2008","unstructured":"Lee NR, Song EK, Jang KY, Choi HN, Moon WS . Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis. Leuk Lymphoma 2008; 49: 247\u2013256.","journal-title":"Leuk Lymphoma"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T12:49:44Z","timestamp":1685969384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFbmt201129"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2011.29","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,28]]},"assertion":[{"value":"2 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}